- Home
- ABAT vs AUTL Comparison
ABAT vs AUTL Comparison
Compare ABAT & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABAT | AUTL |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.6M | 431.2M |
| IPO Year | 2013 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ABAT | AUTL |
|---|---|---|
| Price | $2.66 | $1.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | ★ 3.1M | 1.4M |
| Earning Date | 05-15-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.14 | 28.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $10,120,000.00 |
| Revenue This Year | $145.40 | $669.62 |
| Revenue Next Year | N/A | $79.78 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 496.00 |
| 52 Week Low | $0.86 | $1.11 |
| 52 Week High | $11.49 | $2.70 |
Technical Indicators
Market Signals| Indicator | ABAT | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 25.66 | 31.66 |
| Support Level | $2.22 | N/A |
| Resistance Level | $2.82 | $1.52 |
| Average True Range (ATR) | 0.18 | 0.07 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 2.44 | 8.11 |
Price Performance
Historical ComparisonAbout ABAT American Battery Technology Company
American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. Additionally, the company advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company's activities focus on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.